Group C (low risk of allogenic rejection, high risk for autoimmunity) included 24 T1D islet recipients with HLA-DR3 and/or HLA-DR4 matches (independently of HLA-A and HLA-B matching). Here, HLA-B is linked to type 1 diabetes mellitus.